Outcomes of nontuberculous mycobacteria isolation among lung transplant recipients: A matched case-control with retrospective cohort study

Author:

Grimes Razelle1,Cherrier Lauren2,Nasar Aasya2,Nailor Michael D1,Walia Rajat3,Goodlet Kellie J4

Affiliation:

1. Department of Pharmacy Services, St. Joseph’s Hospital and Medical Center, Phoenix, AZ, USA

2. Department of Pharmacy Services, St. Joseph’s Hospital and Medical Center, Phoenix, AZ, and Division of Transplant Pulmonology, Norton Thoracic Institute, St. Joseph’s Hospital and Medical Center, Phoenix, AZ, USA

3. Division of Transplant Pulmonology, Norton Thoracic Institute, St. Joseph’s Hospital and Medical Center, Phoenix, AZ, USA

4. Department of Pharmacy Practice, Midwestern University College of Pharmacy, Glendale, AZ, USA

Abstract

Abstract Purpose Lung transplant recipients are at increased risk for acquiring nontuberculous mycobacteria (NTM), but the clinical significance of NTM isolation, particularly among patients not meeting guideline-endorsed diagnostic criteria for NTM pulmonary disease, is unclear. Methods A case-control study of lung transplant recipients culture-positive for NTM at a large transplant center during a 7-year period (2013-2019) was performed. Results Twenty-nine cases were matched 1:2 to non-NTM controls. The median time to NTM isolation was 10.7 months post transplant. Only 34.5% of all cases, and half of treated cases, met diagnostic criteria for NTM pulmonary infection. All-cause mortality at 12 months was numerically higher among NTM cases versus controls (20.7% vs 8.6%, P = 0.169); however, no deaths were attributed to NTM. No increase in the 12-month rate of acute rejection was observed (27.6% vs 36.2%, P = 0.477). Recent augmented immunosuppression was associated with increased odds of NTM isolation, while azithromycin prophylaxis was associated with reduced odds of NTM isolation and was not associated with macrolide resistance. Both adverse events and actual or potential drug-drug interactions occurred in more than 90% of treated cases; these events included ocular toxicity, hearing loss, and supratherapeutic calcineurin inhibitor concentrations. Eight of the 14 treated cases (57.1%) required early antibiotic discontinuation due to adverse events or drug-drug interactions. Conclusion Among lung transplant recipients, most patients with NTM isolation did not meet guideline criteria for infection and had outcomes similar to non‒NTM-infected patients, which may reflect transient lung colonization by NTM rather than true disease. As adverse events are common with NTM therapy, limiting unnecessary antibiotic treatment represents an area for future antimicrobial stewardship efforts.

Publisher

Oxford University Press (OUP)

Subject

Health Policy,Pharmacology

Reference34 articles.

1. Epidemiology of infection by nontuberculous mycobacteria;Falkinham;Clin Microbiol Rev,1996

2. Nontuberculous mycobacteria infection in solid organ transplant recipients;Piersimoni;Eur J Clin Microbiol Infect Dis,2012

3. Infections due to nontuberculous mycobacteria in kidney, heart, and liver transplant recipients;Patel;Clin Infect Dis,1994

4. Non-tuberculous mycobacterial infections in solid organ transplant recipients: an update;Abad;J Clin Tubercul Other Mycobact Dis,2015

5. Risk factors for nontuberculous mycobacterial infections in solid organ transplant recipients: a case-control study;Longworth;Transpl Infect Dis,2014

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3